SCHEMBL5058658

SCHEMBL5058658

COc1cc(COCc2cc(OC)c(OC)cc2[N+](=O)[O-])c([N+](=O)[O-])cc1OC

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.56
CYP2D6 P10635 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
CYP3A4 P08684 3/20 0.53
KDM4E B2RXH2 3/20 0.53
MAPT P10636 2/20 0.53
ALOX15 P16050 1/20 0.53
PRKDC P78527 1/20 0.53
HSD17B10 Q99714 1/20 0.53
CYP2C19 P33261 2/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
HTT P42858 1/20 0.48
CYP1A2 P05177 1/20 0.47
TDP1 Q9NUW8 2/20 0.46
GAA P10253 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18314720 0.92 ALDH1A1 (0.56) ALDH1A1CYP2D6L3MBTL1NPC1RAB9A
SCHEMBL9348473 0.90 ALDH1A1 (0.51) ALDH1A1CYP2D6L3MBTL1NPC1RAB9A
SCHEMBL9392804 0.90 ALDH1A1 (0.51) ALDH1A1CYP2D6L3MBTL1NPC1RAB9A
SCHEMBL12978933 0.89 ALDH1A1 (0.56) ALDH1A1CYP2D6L3MBTL1NPC1RAB9A
SCHEMBL9348632 0.88 ALDH1A1 (0.53) ALDH1A1CYP2D6L3MBTL1NPC1RAB9A
SCHEMBL8690 0.86 ALDH1A1 (0.54) ALDH1A1CYP2D6L3MBTL1NPC1RAB9A
SCHEMBL16033288 0.86 ALDH1A1 (0.54) ALDH1A1CYP2D6L3MBTL1NPC1RAB9A
SCHEMBL14226424 0.86 RAB9A (0.52) ALDH1A1CYP2D6L3MBTL1NPC1RAB9A
SCHEMBL28701077 0.86 ALDH1A1 (0.48) ALDH1A1CYP2D6L3MBTL1NPC1RAB9A
SCHEMBL3119487 0.86 ALDH1A1 (0.48) ALDH1A1CYP2D6L3MBTL1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114716453-A Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B 卫材R&D管理有限公司 2022-07-08 CN disclosed
CN-109942560-B Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B 卫材R&D管理有限公司 2022-06-17 CN disclosed
EP-3116558-B1 LIGHT-TRIGGERED SHAPE-CHANGEABLE HYDROGELS AND THEIR USE IN OPTICAL DEVICES CALIFORNIA INST OF TECHN (US) 2018-10-31 EP disclosed
EP-3116558-A1 LIGHT-TRIGGERED SHAPE-CHANGEABLE HYDROGELS AND THEIR USE IN OPTICAL DEVICES California Institute of Technology (US) 2017-01-18 EP disclosed
US-20150258240-A1 LIGHT-TRIGGERED SHAPE-CHANGEABLE HYDROGELS AND THEIR USE IN OPTICAL DEVICES CALIFORNIA INSTITUTE OF TECHNOLOGY 2015-09-17 US disclosed
WO-2015138187-A1 LIGHT-TRIGGERED SHAPE-CHANGEABLE HYDROGELS AND THEIR USE IN OPTICAL DEVICES CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2015-09-17 WO disclosed
US-7393515-B2 Fluorinated compound, water repellent composition and thin film ASAHI GLASS COMPANY, LIMITED (JP) 2008-07-01 US disclosed
EP-1736477-A1 FLUORINE-CONTAINING COMPOUND, WATER REPELLENT COMPOSITION AND THIN FILM Asahi Glass Company, Limited (JP) 2006-12-27 EP disclosed
US-20060222865-A1 Fluorinated compound, water repellent composition and thin film ASAHI GLASS COMPANY, LIMITED (JP) 2006-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060222865-A1 Fluorinated compound, water repellent composition and thin film AFF1, FLOT1, AFF2 ALDH1A1 2644/4885CYP2D6 3361/4885L3MBTL1 694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.